Anti-Aging Drugs Market size was valued at USD 59.75 billion in 2024 and is anticipated to reach USD 215.95 billion by the end of 2037, expanding at around 10.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of anti-aging drugs is assessed at USD 64.72 billion. The growth of the market can be attributed primarily to the rising aging population around the world with the rising hope for extending the healthy lifespan of humans having youthful characteristics. According to the World Health Organization, globally, the percentage of people over 60 years of age will nearly double from 12% to 22% between 2015 and 2050.
In the prevention and treatment of age-related disorders and diseases, anti-aging drugs combine advanced biotechnology and clinical prevention medicines. Anti-aging drugs are mostly used by the baby boomer generation, as well as by consumers who care more about their health and appearance. Using these drugs, the body is able to reverse the effects of aging. The aging process is also being delayed through a wide variety of medical technologies.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
10.3% |
|
Base Year Market Size (2024) |
USD 59.75 billion |
|
Forecast Year Market Size (2037) |
USD 215.95 billion |
|
Regional Scope |
|
Type (Dermal Fillers, Botulinum Toxin)
The global anti-aging drugs market is segmented and analyzed for demand and supply by type into dermal fillers, botulinum toxin, and others. Among these segments, the dermal fillers segment is anticipated to capture the largest market size in the global anti-aging drugs market owing to the increasing dermal filler injections and higher adoption of derma fillers in treating wrinkles and fine lines. For instance, it was found that in 2018, there were approximately 2.6 million dermal filler injections in America.
Our in-depth analysis of the global anti aging drugs market includes the following segments:
|
By Type |
|
|
By Drug Class |
|
|
By Application |
|
|
By Distribution Channel |
|
North America Market Forecast
The North America anti-aging drugs market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037, backed by the increasing number of non-invasive cosmetic treatments, the growing demand for anti-aging products, and the rapid expansion of the personal care industry. For instance, in 2020 nearly 13,280,000 cosmetic minimally invasive surgery procedures were carried out in the United States.
L'Oréal SA has acquired Skinbetter Science, an American skin care brand provided by a doctor, owing to state-of-the-art dermatological science, combining patented effective ingredients with luxurious sensory textures.
Merz Pharma GmbH & Co., officially announced the opening of its latest filler plant in BioPharmaPark, Dessau-Rosslau, Germany.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?